Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Vice President, Technology | May 23, 2018 | May 25, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date May 23, 2018 · Filed May 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld in Trust | 74,666 |
Reported balance
After 2018-05-23 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-05-23 · Exercise / conversion · Acquired 5,000 · Balance 74,666 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Common StockSEC Table I · non-derivative | IndirectHeld in Trust | 72,925 |
Reported balance
After 2018-05-23 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-05-23 · Tax withholding · Disposed 1,741 · Balance 72,925 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2018-05-23 | IndirectHeld In Trust | 0 |
Reported balance
After 2018-05-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-23 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on May 28, 2015. F3: The restricted stock units vested on May 23, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on May 28, 2015.
F3: The restricted stock units vested on May 23, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2018 Filed May 25, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010766 · rdgdoc.xml · derivative · entry 3 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held In Trust Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 1,741 | $13.65 | $23,764.65 |
DisclosureSEC source: 0001437749-18-010766 · rdgdoc.xml · nonDerivative · entry 2 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 72,925 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $13.65 | $68,250.00 |
DisclosureSEC source: 0001437749-18-010766 · rdgdoc.xml · nonDerivative · entry 1 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 74,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-017451 · rdgdoc.xml · derivative · entry 2 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2020-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:26 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 7,500 | $12.65 Strike: $12.65 | $94,875.00 |
DisclosureSEC source: 0001437749-17-017451 · rdgdoc.xml · derivative · entry 1 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 7,500 shares Expires 2024-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · derivative · entry 6 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 20,000 Underlying: Common Stock · 8,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · derivative · entry 5 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 28,000 Underlying: Common Stock · 17,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 8,000 | $13.58 | $108,640.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · nonDerivative · entry 4 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 69,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 8,000 | $5.63 | $45,040.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · nonDerivative · entry 3 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Trust Disclosed balance after: 77,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 6,716 | $14.25 | $95,703.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · nonDerivative · entry 2 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 69,666 Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 15:43 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 17,000 | $5.63 | $95,710.00 |
DisclosureSEC source: 0001437749-17-006401 · rdgdoc.xml · nonDerivative · entry 1 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Trust Disclosed balance after: 76,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 21:08 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 2,574 | $12.26 | $31,557.24 |
DisclosureSEC source: 0001437749-17-001539 · rdgdoc.xml · nonDerivative · entry 1 BITLER STEVEN P · CIK 0001192866 · Vice President, Technology 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 59,382 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.